Diagnosis and management of irritable bowel syndrome: a guide for the generalist
Date
2017
Authors
Linedale, E.C.
Andrews, J.M.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Medical Journal of Australia, 2017; 207(7):309-315
Statement of Responsibility
Ecushla C Linedale, Jane M Andrews
Conference Name
Abstract
Irritable bowel syndrome (IBS) and other functional gastrointestinal disorders (FGIDs) are so prevalent they cannot reasonably have their diagnoses and management based within specialty care. However, delayed diagnosis, lengthy wait times for specialist review, overinvestigation and lack of clear diagnostic communication are common. The intrusive symptoms of IBS and other FGIDs impair patient functioning and reduce quality of life, and come with significant costs to individual patients and the health care system, which could be reduced with timely diagnosis and effective management. IBS, in particular, is no longer a diagnosis of exclusion, and there are now effective dietary and psychological therapies that may be accessed without specialist referral.The faecal calprotectin test is widely available, yet not on the Medical Benefits Schedule, and a normal test result reliably discriminates between people with IBS and patients who warrant specialist referral.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2017 AMPCo Pty Ltd. Produced with Elsevier B.V. All rights reserved.